Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

CURRENT NEUROVASCULAR RESEARCH is an esteemed peer-reviewed journal published by Bentham Science Publishers Ltd, focusing on the intricate relationships within the realms of cellular and molecular neuroscience, developmental neuroscience, and neurology. With an ISSN of 1567-2026 and an E-ISSN of 1875-5739, this journal has been contributing to the field since its inception in 2004 and is poised to continue through 2024. As a resource dedicated to disseminating innovative research findings, CURRENT NEUROVASCULAR RESEARCH is recognized within Category Quartiles as Q3 in multiple fields, including Neurology (clinical) and Developmental Neuroscience. Although classified in the Q4 category for Cellular and Molecular Neuroscience, the journal maintains a crucial role in fostering academic discourse and advancing our understanding of neurovascular dynamics. Researchers, professionals, and students will find valuable insights in this journal, offering access to a diverse range of studies that highlight cutting-edge developments in the field.

Journal of Pediatric Neurology, published by GEORG THIEME VERLAG KG, stands as a dedicated resource in the field of pediatric neurology, navigating the complex interplay of neurological and developmental disorders affecting children. With its ISSN 1304-2580 and E-ISSN 1875-9041, this journal has been a pivotal platform for advancing research since its inception in 2003, and continues to present critical findings and discussions up to 2024. Although currently categorized in the Q4 quartile for both Neurology (Clinical) and Pediatrics, Perinatology and Child Health within Scopus rankings, the journal's commitment to fostering scholarly dialogue is essential for researchers, clinicians, and students dealing with pediatric patients. Its structured coverage of various neurological disorders, treatment strategies, and innovative therapies contributes to the broader understanding of pediatric neurology, despite the challenges noted in its ranking percentile. By encouraging submissions from diverse disciplines, the journal aims to enhance clinical practice and bridge gaps in knowledge, ensuring a multidisciplinary approach to child health and development.

Multiple Sclerosis International is a leading open-access journal dedicated to advancing the scientific understanding of multiple sclerosis (MS) and related neurological disorders. Published by HINDAWI LTD since 2010, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality peer-reviewed articles that cover a diverse range of topics, including epidemiology, treatment strategies, and the latest advancements in MS research. With its commitment to open access, Multiple Sclerosis International ensures that critical findings are readily available to the global community, fostering collaborative efforts to improve patient outcomes and advance therapeutic approaches. The journal not only enhances scholarly discourse in the field but also significantly impacts clinical practices by presenting cutting-edge research and insights.

The Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.